Drug companies may soon have to include prices in TV ads
Health and Human Services Secretary Alex Azar on Monday released a proposal requiring drug companies to reveal how much their medications cost in television ads.
"Right now, drug companies are required to disclose the major side effects a drug can have — but not the effect that buying the drug could have on your wallet," the department said in a statement. The law would apply to brand-name drugs covered by both Medicare and Medicaid, CBS News reports, as long as a typical course of treatment costs more than $35 every month.
PhRMA, the drug industry's largest trade group, said it's open to putting prices up on a website, but believes if prices are revealed in commercials, that could "discourage patients from seeking needed medical care."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
What does Trump's immigration crackdown mean for churches?
Today's Big Question Mass deportations come to 'sacred spaces'
By Joel Mathis, The Week US Published
-
Who is Charles Grassley?
In the Spotlight The Senate Judiciary Committee chairman in charge of Trump's legal agenda
By Joel Mathis, The Week US Published
-
The best TV series with multiple timelines right now
The Week Recommends Narratives that spend significant time in two or more stories can be especially rewarding
By David Faris Published
-
Chinese AI chatbot's rise slams US tech stocks
Speed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
By Peter Weber, The Week US Published
-
US port strike averted with tentative labor deal
Speed Read The strike could have shut down major ports from Texas to Maine
By Peter Weber, The Week US Published
-
Biden expected to block Japanese bid for US Steel
Speed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
By Peter Weber, The Week US Published
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
By Peter Weber, The Week US Published
-
Rupert Murdoch loses 'Succession' court battle
Speed Read Murdoch wanted to give full control of his empire to son Lachlan, ensuring Fox News' right-wing editorial slant
By Peter Weber, The Week US Published
-
Bitcoin surges above $100k in post-election rally
Speed Read Investors are betting that the incoming Trump administration will embrace crypto
By Peter Weber, The Week US Published
-
Enron mystery: 'sick joke' or serious revival?
Speed Read 23 years after its bankruptcy filing, the Texas energy firm has announced its resurrection
By Peter Weber, The Week US Published
-
US charges Indian tycoon with bribery, fraud
Speed Read Indian billionaire Gautam Adani has been indicted by US prosecutors for his role in a $265 million scheme to secure solar energy deals
By Peter Weber, The Week US Published